nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Oral pain—Capecitabine—esophageal cancer	0.0514	0.0941	CcSEcCtD
Phentolamine—Pain in jaw—Capecitabine—esophageal cancer	0.0412	0.0754	CcSEcCtD
Phentolamine—Swelling face—Capecitabine—esophageal cancer	0.0282	0.0516	CcSEcCtD
Phentolamine—Tenderness—Cisplatin—esophageal cancer	0.0209	0.0382	CcSEcCtD
Phentolamine—Pain—Carboplatin—esophageal cancer	0.0189	0.0347	CcSEcCtD
Phentolamine—NISCH—bronchus—esophageal cancer	0.0175	0.0995	CbGeAlD
Phentolamine—NISCH—smooth muscle tissue—esophageal cancer	0.0172	0.0973	CbGeAlD
Phentolamine—Injection site pain—Capecitabine—esophageal cancer	0.0164	0.0301	CcSEcCtD
Phentolamine—NISCH—trachea—esophageal cancer	0.0158	0.0893	CbGeAlD
Phentolamine—ADRA1D—epithelium—esophageal cancer	0.0149	0.0843	CbGeAlD
Phentolamine—Nasal congestion—Cisplatin—esophageal cancer	0.0145	0.0265	CcSEcCtD
Phentolamine—Blood pressure increased—Capecitabine—esophageal cancer	0.0134	0.0246	CcSEcCtD
Phentolamine—Injection site reaction—Capecitabine—esophageal cancer	0.0133	0.0244	CcSEcCtD
Phentolamine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.0121	0.0221	CcSEcCtD
Phentolamine—NISCH—lung—esophageal cancer	0.0113	0.0642	CbGeAlD
Phentolamine—SIGMAR1—bronchus—esophageal cancer	0.0102	0.0579	CbGeAlD
Phentolamine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.01	0.0184	CcSEcCtD
Phentolamine—Myocardial infarction—Cisplatin—esophageal cancer	0.00999	0.0183	CcSEcCtD
Phentolamine—SIGMAR1—smooth muscle tissue—esophageal cancer	0.00999	0.0566	CbGeAlD
Phentolamine—Bradycardia—Cisplatin—esophageal cancer	0.00931	0.017	CcSEcCtD
Phentolamine—SIGMAR1—trachea—esophageal cancer	0.00916	0.052	CbGeAlD
Phentolamine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.0089	0.0163	CcSEcCtD
Phentolamine—Abdominal pain upper—Capecitabine—esophageal cancer	0.0089	0.0163	CcSEcCtD
Phentolamine—ADRA1A—epithelium—esophageal cancer	0.00854	0.0484	CbGeAlD
Phentolamine—Cardiac disorder—Cisplatin—esophageal cancer	0.00849	0.0155	CcSEcCtD
Phentolamine—Flushing—Cisplatin—esophageal cancer	0.00849	0.0155	CcSEcCtD
Phentolamine—Mediastinal disorder—Cisplatin—esophageal cancer	0.00824	0.0151	CcSEcCtD
Phentolamine—Angina pectoris—Capecitabine—esophageal cancer	0.0082	0.015	CcSEcCtD
Phentolamine—Arrhythmia—Cisplatin—esophageal cancer	0.00817	0.0149	CcSEcCtD
Phentolamine—ADRA2C—bronchus—esophageal cancer	0.00802	0.0454	CbGeAlD
Phentolamine—NISCH—lymph node—esophageal cancer	0.00774	0.0439	CbGeAlD
Phentolamine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.0074	0.0135	CcSEcCtD
Phentolamine—Myocardial infarction—Capecitabine—esophageal cancer	0.00736	0.0135	CcSEcCtD
Phentolamine—ADRA2C—trachea—esophageal cancer	0.0072	0.0408	CbGeAlD
Phentolamine—Bradycardia—Capecitabine—esophageal cancer	0.00686	0.0126	CcSEcCtD
Phentolamine—SIGMAR1—lung—esophageal cancer	0.00659	0.0373	CbGeAlD
Phentolamine—ADRA2A—bronchus—esophageal cancer	0.0064	0.0363	CbGeAlD
Phentolamine—Nervous system disorder—Cisplatin—esophageal cancer	0.00637	0.0117	CcSEcCtD
Phentolamine—Tachycardia—Cisplatin—esophageal cancer	0.00634	0.0116	CcSEcCtD
Phentolamine—Cardiac disorder—Capecitabine—esophageal cancer	0.00626	0.0114	CcSEcCtD
Phentolamine—Flushing—Capecitabine—esophageal cancer	0.00626	0.0114	CcSEcCtD
Phentolamine—Angiopathy—Capecitabine—esophageal cancer	0.00612	0.0112	CcSEcCtD
Phentolamine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00608	0.0111	CcSEcCtD
Phentolamine—Hypotension—Cisplatin—esophageal cancer	0.00607	0.0111	CcSEcCtD
Phentolamine—Arrhythmia—Capecitabine—esophageal cancer	0.00602	0.011	CcSEcCtD
Phentolamine—Paraesthesia—Cisplatin—esophageal cancer	0.00583	0.0107	CcSEcCtD
Phentolamine—ADRA2A—trachea—esophageal cancer	0.00574	0.0326	CbGeAlD
Phentolamine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00561	0.0103	CcSEcCtD
Phentolamine—Pain—Cisplatin—esophageal cancer	0.00556	0.0102	CcSEcCtD
Phentolamine—ADRA2C—lung—esophageal cancer	0.00517	0.0293	CbGeAlD
Phentolamine—Hypertension—Capecitabine—esophageal cancer	0.00507	0.00927	CcSEcCtD
Phentolamine—Chest pain—Capecitabine—esophageal cancer	0.005	0.00914	CcSEcCtD
Phentolamine—Nervous system disorder—Capecitabine—esophageal cancer	0.0047	0.00859	CcSEcCtD
Phentolamine—Tachycardia—Capecitabine—esophageal cancer	0.00467	0.00855	CcSEcCtD
Phentolamine—Asthenia—Cisplatin—esophageal cancer	0.00466	0.00853	CcSEcCtD
Phentolamine—Cardiac disorder—Methotrexate—esophageal cancer	0.00466	0.00852	CcSEcCtD
Phentolamine—Angiopathy—Methotrexate—esophageal cancer	0.00455	0.00833	CcSEcCtD
Phentolamine—Mediastinal disorder—Methotrexate—esophageal cancer	0.00452	0.00827	CcSEcCtD
Phentolamine—SIGMAR1—lymph node—esophageal cancer	0.0045	0.0255	CbGeAlD
Phentolamine—Hypotension—Capecitabine—esophageal cancer	0.00448	0.00819	CcSEcCtD
Phentolamine—Diarrhoea—Cisplatin—esophageal cancer	0.00445	0.00813	CcSEcCtD
Phentolamine—Paraesthesia—Capecitabine—esophageal cancer	0.0043	0.00787	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00414	0.00757	CcSEcCtD
Phentolamine—Vomiting—Cisplatin—esophageal cancer	0.00413	0.00756	CcSEcCtD
Phentolamine—ADRA2A—lung—esophageal cancer	0.00413	0.0234	CbGeAlD
Phentolamine—Pain—Capecitabine—esophageal cancer	0.0041	0.00749	CcSEcCtD
Phentolamine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00392	0.00717	CcSEcCtD
Phentolamine—Nausea—Cisplatin—esophageal cancer	0.00386	0.00706	CcSEcCtD
Phentolamine—Abdominal pain—Capecitabine—esophageal cancer	0.00379	0.00693	CcSEcCtD
Phentolamine—Chest pain—Methotrexate—esophageal cancer	0.00372	0.0068	CcSEcCtD
Phentolamine—ADRA2C—lymph node—esophageal cancer	0.00354	0.0201	CbGeAlD
Phentolamine—Nervous system disorder—Methotrexate—esophageal cancer	0.0035	0.0064	CcSEcCtD
Phentolamine—Asthenia—Capecitabine—esophageal cancer	0.00344	0.00629	CcSEcCtD
Phentolamine—Pruritus—Capecitabine—esophageal cancer	0.00339	0.0062	CcSEcCtD
Phentolamine—Hypotension—Methotrexate—esophageal cancer	0.00333	0.0061	CcSEcCtD
Phentolamine—Diarrhoea—Capecitabine—esophageal cancer	0.00328	0.006	CcSEcCtD
Phentolamine—Paraesthesia—Methotrexate—esophageal cancer	0.0032	0.00586	CcSEcCtD
Phentolamine—Dizziness—Capecitabine—esophageal cancer	0.00317	0.00579	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00308	0.00563	CcSEcCtD
Phentolamine—Pain—Methotrexate—esophageal cancer	0.00305	0.00558	CcSEcCtD
Phentolamine—Vomiting—Capecitabine—esophageal cancer	0.00305	0.00557	CcSEcCtD
Phentolamine—Headache—Capecitabine—esophageal cancer	0.003	0.00549	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00292	0.00533	CcSEcCtD
Phentolamine—Nausea—Capecitabine—esophageal cancer	0.00285	0.0052	CcSEcCtD
Phentolamine—ADRA2A—lymph node—esophageal cancer	0.00282	0.016	CbGeAlD
Phentolamine—Abdominal pain—Methotrexate—esophageal cancer	0.00282	0.00516	CcSEcCtD
Phentolamine—Asthenia—Methotrexate—esophageal cancer	0.00256	0.00468	CcSEcCtD
Phentolamine—Pruritus—Methotrexate—esophageal cancer	0.00252	0.00462	CcSEcCtD
Phentolamine—Diarrhoea—Methotrexate—esophageal cancer	0.00244	0.00446	CcSEcCtD
Phentolamine—Dizziness—Methotrexate—esophageal cancer	0.00236	0.00431	CcSEcCtD
Phentolamine—Vomiting—Methotrexate—esophageal cancer	0.00227	0.00415	CcSEcCtD
Phentolamine—Headache—Methotrexate—esophageal cancer	0.00223	0.00409	CcSEcCtD
Phentolamine—Nausea—Methotrexate—esophageal cancer	0.00212	0.00387	CcSEcCtD
Phentolamine—ADRA1A—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000219	0.00079	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PDE4D—esophageal cancer	0.000219	0.00079	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALDH2—esophageal cancer	0.000218	0.000787	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTO1—esophageal cancer	0.000217	0.000784	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—TPI1—esophageal cancer	0.000217	0.000784	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—XIAP—esophageal cancer	0.000216	0.00078	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—NOS3—esophageal cancer	0.000215	0.000776	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—SST—esophageal cancer	0.000213	0.000769	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GNG7—esophageal cancer	0.000208	0.000752	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALDOB—esophageal cancer	0.000208	0.000751	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—GHRL—esophageal cancer	0.000208	0.000749	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GSTT1—esophageal cancer	0.000207	0.000748	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PFN1—esophageal cancer	0.000207	0.000747	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000206	0.000745	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP2A6—esophageal cancer	0.000205	0.00074	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PDE4D—esophageal cancer	0.000204	0.000738	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CTNNA1—esophageal cancer	0.000204	0.000738	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL2—esophageal cancer	0.000203	0.000733	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000203	0.000733	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—NOS2—esophageal cancer	0.000203	0.000732	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PDE4D—esophageal cancer	0.000201	0.000726	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—NOS3—esophageal cancer	0.000201	0.000725	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GAPDH—esophageal cancer	0.0002	0.000723	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ELMO1—esophageal cancer	0.0002	0.000722	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CRABP1—esophageal cancer	0.000199	0.000717	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000196	0.000707	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AKAP13—esophageal cancer	0.000195	0.000705	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—XIAP—esophageal cancer	0.000195	0.000704	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GNG7—esophageal cancer	0.000194	0.000702	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS1—esophageal cancer	0.000194	0.000701	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ENO1—esophageal cancer	0.000194	0.000701	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PSME1—esophageal cancer	0.000191	0.000691	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PSME2—esophageal cancer	0.000191	0.000691	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GNG7—esophageal cancer	0.000191	0.000691	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PSME1—esophageal cancer	0.00019	0.000685	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PSME2—esophageal cancer	0.00019	0.000685	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GNG7—esophageal cancer	0.000189	0.000682	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ANXA1—esophageal cancer	0.000189	0.000682	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ELMO1—esophageal cancer	0.000186	0.000671	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000184	0.000666	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SST—esophageal cancer	0.000184	0.000663	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL2—esophageal cancer	0.000183	0.000662	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—XIAP—esophageal cancer	0.000182	0.000658	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—CREBBP—esophageal cancer	0.000182	0.000657	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AKAP13—esophageal cancer	0.000182	0.000655	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00018	0.000651	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—XIAP—esophageal cancer	0.000179	0.000647	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOTCH3—esophageal cancer	0.000179	0.000646	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—GHRL—esophageal cancer	0.000179	0.000646	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PDE4D—esophageal cancer	0.000179	0.000645	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000178	0.000643	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALDH2—esophageal cancer	0.000177	0.000639	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—FBXW7—esophageal cancer	0.000176	0.000636	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CTNNA1—esophageal cancer	0.000172	0.000622	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	0.000171	0.000618	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	0.000171	0.000618	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL2—esophageal cancer	0.000171	0.000618	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	0.000171	0.000616	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GNG7—esophageal cancer	0.00017	0.000614	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CTNNA1—esophageal cancer	0.00017	0.000612	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL2—esophageal cancer	0.000169	0.000609	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTT1—esophageal cancer	0.000168	0.000608	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000168	0.000605	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP2A6—esophageal cancer	0.000166	0.000601	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000166	0.000599	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SST—esophageal cancer	0.000166	0.000599	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP1B1—esophageal cancer	0.000165	0.000596	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—EP300—esophageal cancer	0.000163	0.00059	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—NOS3—esophageal cancer	0.000163	0.000589	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000162	0.000584	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	0.000162	0.000584	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOTCH2—esophageal cancer	0.000161	0.00058	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PSME1—esophageal cancer	0.00016	0.000578	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PSME2—esophageal cancer	0.00016	0.000578	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—XIAP—esophageal cancer	0.000159	0.000575	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ANXA1—esophageal cancer	0.000159	0.000575	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000159	0.000574	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GNG7—esophageal cancer	0.000158	0.00057	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ENO1—esophageal cancer	0.000158	0.00057	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS1—esophageal cancer	0.000158	0.00057	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PSME1—esophageal cancer	0.000158	0.000569	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PSME2—esophageal cancer	0.000158	0.000569	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ANXA1—esophageal cancer	0.000157	0.000566	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PSME2—esophageal cancer	0.000155	0.000561	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PSME1—esophageal cancer	0.000155	0.000561	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP19A1—esophageal cancer	0.000155	0.000561	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SST—esophageal cancer	0.000155	0.000559	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—EP300—esophageal cancer	0.000153	0.000551	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SST—esophageal cancer	0.000152	0.00055	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOTCH3—esophageal cancer	0.000151	0.000545	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GHRL—esophageal cancer	0.000151	0.000545	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CTNNA1—esophageal cancer	0.000151	0.000544	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL2—esophageal cancer	0.00015	0.000541	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOTCH3—esophageal cancer	0.000149	0.000536	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GHRL—esophageal cancer	0.000149	0.000536	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FBXW7—esophageal cancer	0.000149	0.000536	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—XIAP—esophageal cancer	0.000148	0.000534	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FBXW7—esophageal cancer	0.000146	0.000528	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000145	0.000523	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFBR2—esophageal cancer	0.000142	0.000514	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—HMOX1—esophageal cancer	0.000142	0.000512	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.00014	0.000505	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PSME1—esophageal cancer	0.00014	0.000505	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PSME2—esophageal cancer	0.00014	0.000505	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ANXA1—esophageal cancer	0.000139	0.000503	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL2—esophageal cancer	0.000139	0.000502	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ABCB1—esophageal cancer	0.000136	0.000491	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SST—esophageal cancer	0.000135	0.000489	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOTCH2—esophageal cancer	0.000135	0.000489	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SMAD4—esophageal cancer	0.000135	0.000487	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP1B1—esophageal cancer	0.000134	0.000484	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000133	0.000481	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000132	0.000476	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GHRL—esophageal cancer	0.000132	0.000476	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PSME2—esophageal cancer	0.00013	0.000469	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PSME1—esophageal cancer	0.00013	0.000469	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FBXW7—esophageal cancer	0.00013	0.000469	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000129	0.000467	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000129	0.000464	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP19A1—esophageal cancer	0.000126	0.000455	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SST—esophageal cancer	0.000126	0.000454	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—EP300—esophageal cancer	0.000124	0.000448	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000123	0.000443	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	0.000123	0.000443	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000122	0.000439	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	0.000121	0.000437	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	0.000121	0.000436	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFBR2—esophageal cancer	0.00012	0.000434	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000118	0.000427	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000118	0.000427	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TP53—esophageal cancer	0.000117	0.000422	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—HMOX1—esophageal cancer	0.000115	0.000415	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SMAD4—esophageal cancer	0.000114	0.000411	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—PIK3CA—esophageal cancer	0.000113	0.000408	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SMAD4—esophageal cancer	0.000112	0.000404	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ABCB1—esophageal cancer	0.00011	0.000399	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HIF1A—esophageal cancer	0.00011	0.000398	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	0.00011	0.000397	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TP53—esophageal cancer	0.000109	0.000394	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—KDR—esophageal cancer	0.000106	0.000381	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFBR2—esophageal cancer	0.000105	0.000379	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	9.96e-05	0.00036	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SMAD4—esophageal cancer	9.94e-05	0.000359	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOTCH1—esophageal cancer	9.94e-05	0.000359	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	9.76e-05	0.000352	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—KDR—esophageal cancer	9.53e-05	0.000344	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	9.3e-05	0.000336	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	9.24e-05	0.000333	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	9.17e-05	0.000331	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HIF1A—esophageal cancer	9.16e-05	0.000331	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CREBBP—esophageal cancer	9.09e-05	0.000328	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CREBBP—esophageal cancer	9.01e-05	0.000325	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	8.97e-05	0.000324	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KDR—esophageal cancer	8.9e-05	0.000321	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TP53—esophageal cancer	8.87e-05	0.00032	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—EGFR—esophageal cancer	8.86e-05	0.00032	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KDR—esophageal cancer	8.76e-05	0.000316	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—PIK3CA—esophageal cancer	8.46e-05	0.000306	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	8.38e-05	0.000303	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOTCH1—esophageal cancer	8.25e-05	0.000298	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—NOS3—esophageal cancer	8.14e-05	0.000294	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	8.14e-05	0.000294	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HIF1A—esophageal cancer	8.13e-05	0.000294	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOS3—esophageal cancer	8.07e-05	0.000291	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	8e-05	0.000289	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KDR—esophageal cancer	7.78e-05	0.000281	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—PIK3CA—esophageal cancer	7.69e-05	0.000277	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	7.64e-05	0.000276	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	7.6e-05	0.000274	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	7.56e-05	0.000273	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ERBB2—esophageal cancer	7.55e-05	0.000272	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CREBBP—esophageal cancer	7.48e-05	0.00027	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	7.47e-05	0.00027	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—esophageal cancer	7.44e-05	0.000269	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CREBBP—esophageal cancer	7.38e-05	0.000267	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EGFR—esophageal cancer	7.35e-05	0.000265	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOTCH1—esophageal cancer	7.33e-05	0.000265	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	7.28e-05	0.000263	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KDR—esophageal cancer	7.23e-05	0.000261	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	7.14e-05	0.000258	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—PIK3CA—esophageal cancer	7.02e-05	0.000254	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	6.94e-05	0.000251	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	6.81e-05	0.000246	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	6.81e-05	0.000246	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	6.8e-05	0.000246	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	6.7e-05	0.000242	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCND1—esophageal cancer	6.67e-05	0.000241	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	6.64e-05	0.00024	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—NOS3—esophageal cancer	6.61e-05	0.000239	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	6.53e-05	0.000236	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	6.48e-05	0.000234	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDKN1A—esophageal cancer	6.45e-05	0.000233	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	6.38e-05	0.00023	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	6.36e-05	0.00023	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	6.26e-05	0.000226	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.24e-05	0.000225	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—EP300—esophageal cancer	6.19e-05	0.000223	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	6.17e-05	0.000223	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EP300—esophageal cancer	6.14e-05	0.000222	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	6.07e-05	0.000219	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—esophageal cancer	6.05e-05	0.000218	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	6.02e-05	0.000217	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	5.95e-05	0.000215	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	5.82e-05	0.00021	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	5.8e-05	0.000209	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	5.67e-05	0.000205	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	5.62e-05	0.000203	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	5.56e-05	0.000201	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EP300—esophageal cancer	5.54e-05	0.0002	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	5.53e-05	0.0002	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	5.53e-05	0.0002	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	5.44e-05	0.000196	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	5.35e-05	0.000193	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MYC—esophageal cancer	5.35e-05	0.000193	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	5.26e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EGFR—esophageal cancer	5.23e-05	0.000189	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EP300—esophageal cancer	5.18e-05	0.000187	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	5.17e-05	0.000187	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EP300—esophageal cancer	5.09e-05	0.000184	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—EP300—esophageal cancer	5.03e-05	0.000182	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	4.92e-05	0.000177	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MYC—esophageal cancer	4.83e-05	0.000174	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	4.76e-05	0.000172	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	4.72e-05	0.000171	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PIK3CA—esophageal cancer	4.58e-05	0.000165	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	4.57e-05	0.000165	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PIK3CA—esophageal cancer	4.54e-05	0.000164	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EP300—esophageal cancer	4.53e-05	0.000163	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MYC—esophageal cancer	4.51e-05	0.000163	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MYC—esophageal cancer	4.44e-05	0.00016	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	4.42e-05	0.00016	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	4.41e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—esophageal cancer	4.39e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	4.34e-05	0.000157	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EP300—esophageal cancer	4.2e-05	0.000152	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	4.1e-05	0.000148	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—esophageal cancer	3.97e-05	0.000143	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MYC—esophageal cancer	3.94e-05	0.000142	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	3.86e-05	0.000139	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	3.83e-05	0.000138	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	3.77e-05	0.000136	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PIK3CA—esophageal cancer	3.72e-05	0.000134	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—esophageal cancer	3.7e-05	0.000134	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MYC—esophageal cancer	3.66e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—esophageal cancer	3.65e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	3.58e-05	0.000129	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	3.35e-05	0.000121	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—esophageal cancer	3.24e-05	0.000117	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	3.11e-05	0.000112	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—esophageal cancer	3.01e-05	0.000109	CbGpPWpGaD
